Vox Insights

Find out what’s hitting the top of the Vox inbox through our selection of articles, featuring brand insights and company activity.

Latest articles

Celebrating Five Years

The teams from Vox.Bio and Cambridge Healthcare Research, celebrated our five-year anniversary last week. We...

VoxBio team

Is the era of PowerPoint over?

Vox.Bio has just returned from a thought provoking EphMRA conference in Warsaw. A significant number...

VoxBio team

Empowering patients with pick and mix management tools

Whilst hybrid closed loop systems dominated the sessions and conference narrative at the American Diabetes...

VoxBio team

BHBIA Conference 2019

On 13th and 14th May 2019 BHBIA members descended on a hotel in Windsor for...

VoxBio team

How We Use Secondary Landscape Analysis to Build Confidence in Our Research Insights

We are coming towards the end of a qualitative research project and so far, so...

VoxBio team

Can Consumer Technology Really Improve Long Term Health Outcomes?

The preliminary results of the Apple Heart Study highlight the potential role that consumer digital...

VoxBio team

Why the First 10 Minutes of Qualitative Research are so Important

When budgets are tight and there is a lot of content to cover clients often...

VoxBio team

A Quick Guide to MaxDiff

MaxDiff, also known as best-worst scaling, is a quantitative tool providing prioritisation of needs, attributes...

VoxBio team

Happy Holidays!!

Vox.Bio celebrated the holiday season with a lunch in London for our UK based team....

VoxBio team

Market Research with Oncology Patients

Market research with onocology patients, even those with metastatic or terminal diagnosis is not out...

VoxBio team

UEGW Highlights

Immunology is one of Vox.Bio’s therapeutic areas of expertise and there is a lot happening...

VoxBio team

Everything you need to know about the use of Conjoint in Health Market Research

“Conjoint”, especially in the context of healthcare research, can be considered a daunting and scary...

VoxBio team

How does switching to biosimilars effect patients?

On October 16th AbbVie’s blockbuster Humira will face competition from at least four biosimilars in...

VoxBio team

CAR-T Therapies and the Challenge of Pricing Research

NHS England has become the first EU country to approve a full access deal for...

VoxBio team

Summer Social

For Vox.Bio’s Summer Social event this year we headed out into (a very hot and...

VoxBio team

The Rise of Orals

With four oral JAK-i therapies expected to be available to rheumatoid arthritis patients by the...

VoxBio team

There is a Right and a Wrong Way to do KOL Research

KOL interviews can be a fantastic resource to gain an expert insight in to, for...

VoxBio team

Complementary Therapies in Breast Cancer

ASCO has endorsed SIO guidelines to encourage clinicians to discuss alternative therapies with patients Many...

VoxBio team

ASCO Highlights

The largest clinical oncology conference provided an insight into the future of oncology care from...

VoxBio team

The Research Ripple Effect

The BHBIA’s Annual Conference did not disappoint again this year. The conference topic ‘The Ripple...

VoxBio team

Digital Health in Respiratory Care

Cambridge’s medical innovation community is exploring how digital technology can help to support and enhance...

VoxBio team

Filter by

Contact us

If you want to know more about our understanding of the healthcare and life sciences landscape, get in touch with us.

Get in touch